Gabriele Weitz‐Schmidt

3.2k total citations · 1 hit paper
48 papers, 2.5k citations indexed

About

Gabriele Weitz‐Schmidt is a scholar working on Immunology and Allergy, Molecular Biology and Immunology. According to data from OpenAlex, Gabriele Weitz‐Schmidt has authored 48 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Immunology and Allergy, 20 papers in Molecular Biology and 18 papers in Immunology. Recurrent topics in Gabriele Weitz‐Schmidt's work include Cell Adhesion Molecules Research (29 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Chemical Synthesis and Analysis (11 papers). Gabriele Weitz‐Schmidt is often cited by papers focused on Cell Adhesion Molecules Research (29 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Chemical Synthesis and Analysis (11 papers). Gabriele Weitz‐Schmidt collaborates with scholars based in Switzerland, United States and Germany. Gabriele Weitz‐Schmidt's co-authors include Karl Welzenbach, Ulrich Hommel, Joerg Kallen, Sylvain Cottens, Volker Brinkmann, Yoshikazu Takada, Christian Bruns, Chi‐Huey Wong, Timothy A. Springer and Paul Ramage and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Gabriele Weitz‐Schmidt

48 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

2001 844 citations Gabriele Weitz‐Schmidt, Karl Welzenbach et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gabriele Weitz‐Schmidt Switzerland	23	965	753	626	598	357	48	2.5k
Sylvain Cottens Switzerland	16	1.8k 1.9×	813 1.1×	257 0.4×	770 1.3×	309 0.9×	26	3.5k
Karl Welzenbach Switzerland	15	586 0.6×	636 0.8×	353 0.6×	434 0.7×	103 0.3×	18	1.7k
William Westlin United States	24	1.2k 1.3×	492 0.7×	346 0.6×	175 0.3×	192 0.5×	65	3.0k
Dietmar Seiffert United States	34	862 0.9×	324 0.4×	757 1.2×	245 0.4×	193 0.5×	117	3.8k
Claudia K. Derian United States	39	1.6k 1.6×	684 0.9×	309 0.5×	272 0.5×	241 0.7×	63	4.6k
D P Via United States	25	1.4k 1.4×	632 0.8×	252 0.4×	967 1.6×	66 0.2×	46	3.2k
Fernando Vidal‐Vanaclocha Spain	34	1.6k 1.6×	942 1.3×	255 0.4×	218 0.4×	137 0.4×	72	3.1k
Arimichi Takabayashi Japan	29	1.8k 1.8×	1.0k 1.4×	247 0.4×	484 0.8×	81 0.2×	75	4.0k
Michael Scully United Kingdom	28	675 0.7×	169 0.2×	192 0.3×	360 0.6×	199 0.6×	121	2.8k
Joëlle Simony-Lafontaine France	19	585 0.6×	647 0.9×	668 1.1×	450 0.8×	29 0.1×	25	3.4k

Countries citing papers authored by Gabriele Weitz‐Schmidt

Since Specialization

Citations

This map shows the geographic impact of Gabriele Weitz‐Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriele Weitz‐Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriele Weitz‐Schmidt more than expected).

Fields of papers citing papers by Gabriele Weitz‐Schmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriele Weitz‐Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriele Weitz‐Schmidt. The network helps show where Gabriele Weitz‐Schmidt may publish in the future.

Co-authorship network of co-authors of Gabriele Weitz‐Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriele Weitz‐Schmidt. A scholar is included among the top collaborators of Gabriele Weitz‐Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriele Weitz‐Schmidt. Gabriele Weitz‐Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weitz‐Schmidt, Gabriele, Thomas Schürpf, & Timothy A. Springer. (2011). The C-Terminal αI Domain Linker as a Critical Structural Element in the Conformational Activation of αI Integrins. Journal of Biological Chemistry. 286(49). 42115–42122. 12 indexed citations

Evenou, Jean-Pierre, Jürgen Wagner, Gerhard Zenke, et al.. (2009). The Potent Protein Kinase C-Selective Inhibitor AEB071 (Sotrastaurin) Represents a New Class of Immunosuppressive Agents Affecting Early T-Cell Activation. Journal of Pharmacology and Experimental Therapeutics. 330(3). 792–801. 116 indexed citations

Soleimani, Behzad, Grazyna Wieczorek, Andreas Katopodis, et al.. (2007). Anti–LFA-1 Monotherapy Prevents Neointimal Formation in a Murine Model of Transplant Intimal Hyperplasia. The Journal of Heart and Lung Transplantation. 26(7). 724–731. 4 indexed citations

Schramm, René, Michael D. Menger, Yves Harder, et al.. (2006). Statins inhibit lymphocyte homing to peripheral lymph nodes. Immunology. 120(3). 315–324. 23 indexed citations

Wattanasin, Sompong, Joerg Kallen, Michael Sabio, et al.. (2004). 1,4-Diazepane-2,5-diones as novel inhibitors of LFA-1. Bioorganic & Medicinal Chemistry Letters. 15(4). 1217–1220. 34 indexed citations

Burkhart, Christoph, Christoph Heusser, Randall E. Morris, et al.. (2004). Pharmacodynamics in the Development of New Immunosuppressive Drugs. Therapeutic Drug Monitoring. 26(6). 588–592. 14 indexed citations

Weitz‐Schmidt, Gabriele, Karl Welzenbach, Janet Dawson, & Joerg Kallen. (2004). Improved Lymphocyte Function-associated Antigen-1 (LFA-1) Inhibition by Statin Derivatives. Journal of Biological Chemistry. 279(45). 46764–46771. 55 indexed citations

Li, Xiang, Daniel Klintman, Gabriele Weitz‐Schmidt, René Schramm, & Henrik Thorlacius. (2004). Lymphocyte function antigen‐1 mediates leukocyte adhesion and subsequent liver damage in endotoxemic mice. British Journal of Pharmacology. 141(4). 709–716. 38 indexed citations

Ullrich, Thomas, Karl Baumann, Karl Welzenbach, et al.. (2004). Statin-derived 1,3-oxazinan-2-ones as submicromolar inhibitors of LFA-1/ICAM-1 interaction: stabilization of the metabolically labile vanillyl side chain. Bioorganic & Medicinal Chemistry Letters. 14(10). 2483–2487. 18 indexed citations

10.

Wattanasin, Sompong, Rainer Albert, Claus Ehrhardt, et al.. (2003). 1,4-Diazepane-2-ones as novel inhibitors of LFA-1. Bioorganic & Medicinal Chemistry Letters. 13(3). 499–502. 40 indexed citations

11.

Weitz‐Schmidt, Gabriele. (2003). Lymphocyte Function-Associated Antigen-1 Blockade by Statins: Molecular Basis and Biological Relevance. Endothelium. 10(1). 43–47. 29 indexed citations

12.

Welzenbach, Karl, Ulrich Hommel, & Gabriele Weitz‐Schmidt. (2002). Small Molecule Inhibitors Induce Conformational Changes in the I Domain and the I-like Domain of Lymphocyte Function-associated Antigen-1. Journal of Biological Chemistry. 277(12). 10590–10598. 66 indexed citations

13.

Weitz‐Schmidt, Gabriele. (2002). Statins as anti-inflammatory agents. Trends in Pharmacological Sciences. 23(10). 482–487. 282 indexed citations

14.

Weetall, Marla, Ronald J. Hugo, Susan West, et al.. (2001). A Homogeneous Fluorometric Assay for Measuring Cell Adhesion to Immobilized Ligand Using V-Well Microtiter Plates. Analytical Biochemistry. 293(2). 277–287. 38 indexed citations

15.

Weitz‐Schmidt, Gabriele, Karl Welzenbach, Volker Brinkmann, et al.. (2001). Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nature Medicine. 7(6). 687–692. 844 indexed citations breakdown →

16.

Weitz‐Schmidt, Gabriele, A. Krause, Thomas Moll, et al.. (2001). Species-Specific and Conserved Epitopes on Mouse and Human E-Selectin Important for Leukocyte Adhesion. Experimental Cell Research. 269(2). 266–274. 13 indexed citations

17.

Peri, Francesco, Pascal Dumy, Yoshihiro Yokokawa, et al.. (1999). Assembly of binding loops on aromatic templates as VCAM-1 mimetics. Journal of Peptide Science. 5(7). 313–322. 6 indexed citations

18.

Kallen, Joerg, Karl Welzenbach, Paul Ramage, et al.. (1999). Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain 1 1Edited by F. E. Cohen. Journal of Molecular Biology. 292(1). 1–9. 214 indexed citations

19.

Lampe, Thomas, Gabriele Weitz‐Schmidt, & Chi‐Huey Wong. (1998). Parallel Synthesis of Sialyl Lewis X Mimetics on a Solid Phase: Access to a Library of Fucopeptides. Angewandte Chemie International Edition. 37(12). 1707–1711. 47 indexed citations

20.

Weitz‐Schmidt, Gabriele, et al.. (1996). An E-Selectin Binding Assay Based on a Polyacrylamide-Type Glycoconjugate. Analytical Biochemistry. 238(2). 184–190. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact